The impact of anxiety and catastrophizing on interleukin-6 responses to acute painful stress

Asimina Lazaridou, Marc O Martel, Christine M Cahalan, Marise C Cornelius, Olivia Franceschelli, Claudia M Campbell, Jennifer A Haythornthwaite, Michael Smith, Joseph Riley, Robert R Edwards, Asimina Lazaridou, Marc O Martel, Christine M Cahalan, Marise C Cornelius, Olivia Franceschelli, Claudia M Campbell, Jennifer A Haythornthwaite, Michael Smith, Joseph Riley, Robert R Edwards

Abstract

Objective: To examine the influence of anxiety and pain-related catastrophizing on the time course of acute interleukin-6 (IL-6) responses to standardized noxious stimulation among patients with chronic pain.

Methods: Data were collected from 48 participants in the following demographically matched groups: patients with chronic pain (n=36) and healthy controls (n=12). Participants underwent a series of Quantitative Sensory Testing (QST) procedures assessing responses to mechanical and thermal stimuli during two separate visits, in a randomized order. One visit consisted of standard, moderately painful QST procedures, while the other visit involved nonpainful analogs to these testing procedures. Blood samples were taken at baseline, and then for up to 2 hours after QST in order to study the time course of IL-6 responses.

Results: Results of multilevel analyses revealed that IL-6 responses increased across assessment time points in both visits (p<0.001). While patients with chronic pain and healthy controls did not differ in the magnitude of IL-6 responses, psychological factors influenced IL-6 trajectories only in the chronic pain group. Among patients, increases in catastrophizing over the course of the QST session were associated with elevated IL-6 responses only during the painful QST session (p<0.05). When controlling for anxiety, results indicated that the main multilevel model among patients remained significant (p<0.05).

Conclusion: Under specific conditions (eg, application of a painful stressor), catastrophizing may be associated with amplified proinflammatory responses in patients with persistent pain. These findings suggest that psychosocial interventions that reduce negative pain-related cognitions may benefit patients' inflammatory profiles.

Keywords: anxiety; catastrophizing; chronic pain; interleukin-6.

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
IL-6 levels in chronic pain patients (FM and OA). Data points are group means; error bars represent standard deviation. Abbreviations: FM, fibromyalgia; IL-6, interleukin-6; OA, osteoarthritis.
Figure 2
Figure 2
Interleukin-6 (IL-6) levels in healthy controls. Data points are group means; error bars represent standard deviation.

References

    1. March L, Smith EU, Hoy DG, et al. Burden of disability due to musculoskeletal (MSK) disorders. Best Pract Res Clin Rheumatol. 2014;28(3):353–366.
    1. Clauw DJ. Fibromyalgia: more than just a musculoskeletal disease. Am Fam Physician. 1995;52(3):843–851.
    1. Clauw DJ. Fibromyalgia: update on mechanisms and management. J Clin Rheumatol. 2007;13(2):102–109.
    1. Skaer TL. Fibromyalgia: disease synopsis, medication cost effectiveness and economic burden. Pharmacoeconomics. 2014;32(5):457–466.
    1. Cross M, Smith E, Hoy D, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73(7):1323–1330.
    1. Rodriguez-Pinto I, Agmon-Levin N, Howard A, Shoenfeld Y. Fibromyalgia and cytokines. Immunol Lett. 2014;161(2):200–203.
    1. Greene MA, Loeser RF. Aging-related inflammation in osteoarthritis. Osteoarthritis Cartilage. 2015;23(11):1966–1971.
    1. Agmon-Levin N, Zafrir Y, Kivity S, Balofsky A, Amital H, Shoenfeld Y. Chronic fatigue syndrome and fibromyalgia following immunization with the hepatitis B vaccine: another angle of the ‘autoimmune (auto-inflammatory) syndrome induced by adjuvants’ (ASIA) Immunol Res. 2014;60(2–3):376–383.
    1. Imamura M, Targino RA, Hsing WT, et al. Concentration of cytokines in patients with osteoarthritis of the knee and fibromyalgia. Clin Interv Aging. 2014;9:939–944.
    1. van West D, Maes M. Neuroendocrine and immune aspects of fibromyalgia. BioDrugs. 2001;15(8):521–531.
    1. Uceyler N, Hauser W, Sommer C. Systematic review with meta-analysis: cytokines in fibromyalgia syndrome. BMC Musculoskelet Disord. 2011;12:245.
    1. Doss F, Menard J, Hauschild M, et al. Elevated IL-6 levels in the synovial fluid of osteoarthritis patients stem from plasma cells. Scand J Rheumatol. 2007;36(2):136–139.
    1. Imamura M, Ezquerro F, Marcon Alfieri F, et al. Serum levels of proinflammatory cytokines in painful knee osteoarthritis and sensitization. Int J Inflam. 2015;2015:329792.
    1. Rosas-Ballina M, Tracey KJ. Cholinergic control of inflammation. J Intern Med. 2009;265(6):663–679.
    1. Olshansky B. Vagus nerve modulation of inflammation: Cardiovascular implications. Trends Cardiovasc Med. 2016;26(1):1–11.
    1. Elenkov IJ, Iezzoni DG, Daly A, Harris AG, Chrousos GP. Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation. 2005;12(5):255–269.
    1. Woda A, Picard P, Dutheil F. Dysfunctional stress responses in chronic pain. Psychoneuroendocrinology. 2016;71:127–135.
    1. Tian R, Hou G, Li D, Yuan TF. A possible change process of inflammatory cytokines in the prolonged chronic stress and its ultimate implications for health. ScientificWorldJournal. 2014;2014:780616.
    1. Dantzer R, Kelley KW. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun. 2007;21(2):153–160.
    1. Bruunsgaard H, Pedersen AN, Schroll M, Skinhoj P, Pedersen BK. Impaired production of proinflammatory cytokines in response to lipopolysaccharide (LPS) stimulation in elderly humans. Clin Exp Immunol. 1999;118(2):235–241.
    1. Geiss A, Varadi E, Steinbach K, Bauer HW, Anton F. Psychoneuroimmunological correlates of persisting sciatic pain in patients who underwent discectomy. Neurosci Lett. 1997;237(2–3):65–68.
    1. Bazzichi L, Dini M, Rossi A, et al. Muscle modifications in fibromyalgic patients revealed by surface electromyography (SEMG) analysis. BMC Musculoskelet Disord. 2009;10:36.
    1. Gur A, Karakoc M, Nas K, et al. Cytokines and depression in cases with fibromyalgia. J Rheumatol. 2002;29(2):358–361.
    1. Wang H, Moser M, Schiltenwolf M, Buchner M. Circulating cytokine levels compared to pain in patients with fibromyalgia – a prospective longitudinal study over 6 months. J Rheumatol. 2008;35(7):1366–1370.
    1. Edwards RR, Kronfli T, Haythornthwaite JA, Smith MT, McGuire L, Page GG. Association of catastrophizing with interleukin-6 responses to acute pain. Pain. 2008;140(1):135–144.
    1. Sloan TJ, Gupta R, Zhang W, Walsh DA. Beliefs about the causes and consequences of pain in patients with chronic inflammatory or noninflammatory low back pain and in pain-free individuals. Spine (Phila Pa 1976) 2008;33(9):966–972.
    1. Parker JC, Smarr KL, Angelone EO, et al. Psychological factors, immunologic activation, and disease activity in rheumatoid arthritis. Arthritis Care Res. 1992;5(4):196–201.
    1. Grant DM, Beck JG. What predicts the trajectory of rumination?: a prospective evaluation. J Anxiety Disord. 2010;24(5):480–486.
    1. Sullivan MJ, Neish NR. Catastrophizing, anxiety and pain during dental hygiene treatment. Community Dent Oral Epidemiol. 1998;26(5):344–349.
    1. Turner JA, Aaron LA. Pain-related catastrophizing: what is it? Clin J Pain. 2001;17(1):65–71.
    1. Pinto PR, McIntyre T, Almeida A, Araujo-Soares V. The mediating role of pain catastrophizing in the relationship between presurgical anxiety and acute postsurgical pain after hysterectomy. Pain. 2012;153(1):218–226.
    1. Campbell CM, Kronfli T, Buenaver LF, et al. Situational versus dispositional measurement of catastrophizing: associations with pain responses in multiple samples. J Pain. 2010;11(5):443–453.e442.
    1. Edwards RR, Bingham CO, 3rd, Bathon J, Haythornthwaite JA. Catastrophizing and pain in arthritis, fibromyalgia, and other rheumatic diseases. Arthritis Rheum. 2006;55(2):325–332.
    1. Leung L. Pain catastrophizing: an updated review. Indian J Psychol Med. 2012;34(3):204–217.
    1. Sullivan MJ, Martel MO, Tripp D, Savard A, Crombez G. The relation between catastrophizing and the communication of pain experience. Pain. 2006;122(3):282–288.
    1. Edwards RR, Cahalan C, Mensing G, Smith M, Haythornthwaite JA. Pain, catastrophizing, and depression in the rheumatic diseases. Nat Rev Rheumatol. 2011;7(4):216–224.
    1. Sullivan MJ, Thorn B, Haythornthwaite JA, et al. Theoretical perspectives on the relation between catastrophizing and pain. Clin J Pain. 2001;17(1):52–64.
    1. Masselin-Dubois A, Attal N, Fletcher D, et al. Are psychological predictors of chronic postsurgical pain dependent on the surgical model? A comparison of total knee arthroplasty and breast surgery for cancer. J Pain. 2013;14(8):854–864.
    1. Craner JR, Gilliam WP, Sperry JA. Rumination, magnification, and helplessness: how do different aspects of pain catastrophizing relate to pain severity and functioning? Clin J Pain. 2016;32(12):1028–1035.
    1. Schoenfeld-Smith K, Petroski GF, Hewett JE, et al. A biopsychosocial model of disability in rheumatoid arthritis. Arthritis Care Res. 1996;9(5):368–375.
    1. Parker JC, Smarr KL, Angelone EO, et al. Psychological factors, immunologic activation, and disease activity in rheumatoid arthritis. Arthritis Care Res. 1992;5(4):196–201.
    1. Boyden SD, Hossain IN, Wohlfahrt A, Lee YC. Non-inflammatory causes of pain in patients with rheumatoid arthritis. Curr Rheumatol Rep. 2016;18(6):30.
    1. Affleck G, Tennen H, Urrows S, Higgins P. Neuroticism and the pain-mood relation in rheumatoid arthritis: insights from a prospective daily study. J Consult Clin Psychol. 1992;60(1):119–126.
    1. O’Donovan A, Hughes BM, Slavich GM, et al. Clinical anxiety, cortisol and interleukin-6: evidence for specificity in emotion-biology relationships. Brain Behav Immun. 2010;24(7):1074–1077.
    1. Sturgeon JA, Zautra AJ. State and trait pain catastrophizing and emotional health in rheumatoid arthritis. Ann Behav Med. 2013;45(1):69–77.
    1. Edwards RR, Fillingim RB. Effects of age on temporal summation and habituation of thermal pain: clinical relevance in healthy older and younger adults. J Pain. 2001;2(6):307–317.
    1. Ge HY, Madeleine P, Arendt-Nielsen L. Gender differences in pain modulation evoked by repeated injections of glutamate into the human trapezius muscle. Pain. 2005;113(1–2):134–140.
    1. De Jongh RF, Vissers KC, Meert TF, Booij LH, De Deyne CS, Heylen RJ. The role of interleukin-6 in nociception and pain. Anesth Analg. 2003;96(4):1096–1103.
    1. Beilin B, Bessler H, Mayburd E, et al. Effects of preemptive analgesia on pain and cytokine production in the postoperative period. Anesthesiology. 2003;98(1):151–155.
    1. Lee YC, Lu B, Bathon JM, et al. Pain sensitivity and pain reactivity in osteoarthritis. Arthritis Care Res (Hoboken) 2011;63(3):320–327.
    1. Edwards RR, Wasan AD, Bingham CO, 3rd, et al. Enhanced reactivity to pain in patients with rheumatoid arthritis. Arthritis Res Ther. 2009;11(3):R61.
    1. Cleeland CS, Ryan KM. Pain assessment: global use of the brief pain inventory. Ann Acad Med Singapore. 1994;23(2):129–138.
    1. Sullivan MJL, B S, Pivik J. The pain catastrophizing scale: development and validation. Psychological Assessment. 1995;7:524–532.
    1. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571.
    1. Edwards RR, Mensing G, Cahalan C, et al. Alteration in pain modulation in women with persistent pain after lumpectomy: influence of catastrophizing. J Pain Symptom Manage. 2013;46(1):30–42.
    1. Edwards RR, Wasan AD, Michna E, Greenbaum S, Ross E, Jamison RN. Elevated pain sensitivity in chronic pain patients at risk for opioid misuse. J Pain. 2011;12(9):953–963.
    1. Peugh JL. A practical guide to multilevel modeling. J Sch Psychol. 2010;48(1):85–112.
    1. Singer JD, Willett JB. Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. Oxford; New York: Oxford University Press; 2003.
    1. Snijders TAB, Bosker RJ. Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modeling. London; Thousand Oaks, Calif: Sage Publications; 1999.
    1. West BT, Welch KB, Galecki AT. Linear Mixed Models: A Practical Guide using Statistical Software. Boca Raton: Chapman & Hall/CRC; 2007.
    1. Friedman EM, Hayney M, Love GD, Singer BH, Ryff CD. Plasma interleukin-6 and soluble IL-6 receptors are associated with psychological well-being in aging women. Health Psychol. 2007;26(3):305–313.
    1. Chatkoff DK, Leonard MT, Maier KJ. Pain catastrophizing differs between and within West Haven-Yale Multidimensonal Pain Inventory (MPI) pain adjustment classifications: theoretical and clinical implications from preliminary data. Clin J Pain. 2015;31(4):349–354.
    1. Iwaki R, Arimura T, Jensen MP, et al. Global catastrophizing vs catastrophizing subdomains: assessment and associations with patient functioning. Pain Med. 2012;13(5):677–687.
    1. Cheng J, Edwards LJ, Maldonado-Molina MM, Komro KA, Muller KE. Real longitudinal data analysis for real people: building a good enough mixed model. Stat Med. 2010;29(4):504–520.
    1. Enders CK, Tofighi D. Centering predictor variables in cross-sectional multilevel models: a new look at an old issue. Psychol Methods. 2007;12:121–138.
    1. Nezlek J. Multilevel random coefficient analyses of event and interval contingent data in social and personality psychology research. Psychological Bulletin. 2001;27:771–785.
    1. Kopala-Sibley DC, Zuroff DC, Russell JJ, Moskowitz DS, Paris J. Understanding heterogeneity in borderline personality disorder: differences in affective reactivity explained by the traits of dependency and self-criticism. J Abnorm Psychol. 2012;121(3):680–691.
    1. Russell JJ, Moskowitz DS, Zuroff DC, Bleau P, Pinard G, Young SN. Anxiety, emotional security and the interpersonal behavior of individuals with social anxiety disorder. Psychol Med. 2011;41(3):545–554.
    1. Wallace D, Green BS. Analysis of repeated measures designs with linear mixed models. In: Moscovitz DM, Hershberger SL, editors. Modeling Intraindividual Variability with Repeated Measures Data. NJ: Lawrence Erlbaum, Mahwah; 2002.
    1. Schwartz JE, Stone AA. Strategies for analyzing ecological momentary assessment data. Health Psychol. 1998;17(1):6–16.
    1. Singer JD, Willett JB. Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. New York: Oxford University Press, Oxford; 2003.
    1. Singer JD. Using SAS PROC MIXED to fit multilevel models, hierarchical models, and individual growth models. J Edu Behav Statistics. 1998;23:323–325.
    1. Brown CA, El-Deredy W, Jones AK. When the brain expects pain: common neural responses to pain anticipation are related to clinical pain and distress in fibromyalgia and osteoarthritis. Eur J Neurosci. 2014;39(4):663–672.
    1. Brummett CM, Urquhart AG, Hassett AL, et al. Characteristics of fibromyalgia independently predict poorer long-term analgesic outcomes following total knee and hip arthroplasty. Arthritis Rheumatol. 2015;67(5):1386–1394.
    1. Martel MO, Finan PH, Dolman AJ, et al. Self-reports of medication side effects and pain-related activity interference in patients with chronic pain: a longitudinal cohort study. Pain. 2015;156(6):1092–1100.
    1. Lee YC, Lu B, Bathon JM, et al. Pain sensitivity and pain reactivity in osteoarthritis. Arthritis Care Res (Hoboken) 2011;63(3):320–327.
    1. al’Absi M, Wittmers LE, Ellestad D, et al. Sex differences in pain and hypothalamic-pituitary-adrenocortical responses to opioid blockade. Psychosom Med. 2004;66(2):198–206.
    1. Lutgendorf SK, Logan H, Costanzo E, Lubaroff D. Effects of acute stress, relaxation, and a neurogenic inflammatory stimulus on interleukin-6 in humans. Brain Behav Immun. 2004;18(1):55–64.
    1. Edlinger C, Schreiber C, Goebel B, et al. Impact of Moderate Altitude on Pro-Inflammatory Cytokines in Healthy Volunteers. Clin Lab. 2017;63(9):1545–1548.
    1. Haack M, Kraus T, Schuld A, Dalal M, Koethe D, Pollmacher T. Diurnal variations of interleukin-6 plasma levels are confounded by blood drawing procedures. Psychoneuroendocrinology. 2002;27(8):921–931.
    1. Copeland S, Warren HS, Lowry SF, et al. Acute inflammatory response to endotoxin in mice and humans. Clin Diagn Lab Immunol. 2005;12(1):60–67.
    1. Penninx BW, Abbas H, Ambrosius W, et al. Inflammatory markers and physical function among older adults with knee osteoarthritis. J Rheumatol. 2004;31(10):2027–2031.
    1. Wallace DJ, Linker-Israeli M, Hallegua D, Silverman S, Silver D, Weisman MH. Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology (Oxford) 2001;40(7):743–749.
    1. Evers AW, Kraaimaat FW, Geenen R, Jacobs JW, Bijlsma JW. Stress-vulnerability factors as long-term predictors of disease activity in early rheumatoid arthritis. J Psychosom Res. 2003;55(4):293–302.
    1. Parker JC, Smarr KL, Walker SE, et al. Biopsychosocial parameters of disease activity in rheumatoid arthritis. Arthritis Care Res. 1991;4(2):73–80.
    1. Zautra AJ, Burleson MH, Matt KS, Roth S, Burrows L. Interpersonal stress, depression, and disease activity in rheumatoid arthritis and osteoarthritis patients. Health Psychol. 1994;13(2):139–148.
    1. Filiano AJ, Gadani SP, Kipnis J. How and why do T cells and their derived cytokines affect the injured and healthy brain? Nat Rev Neurosci. 2017;18(6):375–384.
    1. Buenaver LF, Edwards RR, Haythornthwaite JA. Pain-related catastrophizing and perceived social responses: Inter-relationships in the context of chronic pain. Pain. 2007;127(3):234–242.
    1. Christidis N, Ghafouri B, Larsson A, et al. Comparison of the levels of pro-inflammatory cytokines released in the vastus lateralis muscle of patients with fibromyalgia and healthy controls during contractions of the quadriceps muscle–A Microdialysis Study. PLoS One. 2015;10(12):e0143856.
    1. Camacho EM, Verstappen SM, Chipping J, Symmons DP. Learned helplessness predicts functional disability, pain and fatigue in patients with recent-onset inflammatory polyarthritis. Rheumatology (Oxford) 2013;52(7):1233–1238.
    1. Maes M, Song C, Lin A, et al. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine. 1998;10(4):313–318.
    1. Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci U S A. 2003;100(15):9090–9095.
    1. Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46–56.
    1. Irwin MR, Miller AH. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun. 2007;21(4):374–383.
    1. Chandrashekara S, Jayashree K, Veeranna HB, et al. Effects of anxiety on TNF-alpha levels during psychological stress. J Psychosom Res. 2007;63(1):65–69.
    1. Anisman H, Merali Z, Poulter MO, Hayley S. Cytokines as a precipitant of depressive illness: animal and human studies. Curr Pharm Des. 2005;11(8):963–972.
    1. Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(2):201–217.
    1. Manning PJ, Sutherland WH, McGrath MM, de Jong SA, Walker RJ, Williams MJ. Postprandial cytokine concentrations and meal composition in obese and lean women. Obesity (Silver Spring) 2008;16(9):2046–2052.
    1. Silverman HA, Dancho M, Regnier-Golanov A, et al. Brain region-specific alterations in the gene expression of cytokines, immune cell markers and cholinergic system components during peripheral endotoxin-induced inflammation. Mol Med. 2015;20:601–611.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever